0 Évaluations
ID

20229

Description

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one.

Mots-clés

Versions (2)
  1. 15/02/2017 15/02/2017 -
  2. 20/02/2017 20/02/2017 -
Téléchargé le

15 février 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    Anglais

    Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    1 Formulaires  
    Toast Criteria
    Description

    Toast Criteria

    1. For the qualifying stroke, please categories the ethnologic below (indicate one only)
    Description

    Etiologic subtype

    Type de données

    integer

    Concomitant Medication
    Description

    Concomitant Medication

    Alias
    UMLS CUI-1
    C2347852 (Concomitant Agent)
    2. Are any medications listed below currently being taken on the day of visit 1?
    Description

    Medication taken

    Type de données

    boolean

    If yes, please indicate which, if any, of the following are currently being taken:
    Description

    If the patient is taking any restricted (bolded) concomitant medications (see facing page), please ensure these are stopped prior to randomasation.

    Type de données

    integer

    ACE Inhibitors
    Description

    ACE Inhibitors

    Alias
    UMLS CUI-1
    C0003015 (Angiotensin-Converting Enzyme Inhibitors)
    SNOMED
    372733002
    3. Are ACE Inhibitors currently being taken on the day of visit 1?
    Description

    ACE Inhibitors currently taken

    Type de données

    boolean

    Name of ACE Inhibitor and Total Daily Dose
    Description

    Name of ACE Inhibitor and Total Daily Dose

    Type de données

    text

    Retour au début de la page

    Similar models

    Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    Toast Criteria
    Item
    1. For the qualifying stroke, please categories the ethnologic below (indicate one only)
    integer
    Etiologic subtype
    Code List
    1. For the qualifying stroke, please categories the ethnologic below (indicate one only)
    CL Item
    Large-artery atherosclerosis (1)
    CL Item
    Cardioembolism (2)
    CL Item
    Small-artery occlusion (lacune) (3)
    CL Item
    Acute stroke of other determined etiology (4)
    CL Item
    Stroke of underdetermined etiology (5)
    Item Group
    Concomitant Medication
    C2347852 (UMLS CUI-1)
    Medication taken
    Item
    2. Are any medications listed below currently being taken on the day of visit 1?
    boolean
    Item
    If yes, please indicate which, if any, of the following are currently being taken:
    integer
    If yes, please indicate which
    Code List
    If yes, please indicate which, if any, of the following are currently being taken:
    CL Item
    Dipyridamole (0)
    CL Item
    Aspirin (1)
    CL Item
    Ticlopidine (2)
    CL Item
    Clopidogrel (3)
    CL Item
    Aspirin/extended release Dipyridamole (4)
    CL Item
    Oral anticoagulants (5)
    CL Item
    Nitrates (oral or topical) (6)
    CL Item
    Estrogen replacement without progesterone (7)
    CL Item
    Estrogen replacement with progesterone (8)
    CL Item
    Digitalis (9)
    CL Item
    Statins (10)
    CL Item
    Fibrates (11)
    CL Item
    Dilitazem/Verapamil (12)
    CL Item
    Other calcium channel blockers (13)
    CL Item
    Alpha-blocker (14)
    CL Item
    Direct vasodilators (15)
    CL Item
    Angiotensin Receptor Blocker (ARB) (16)
    CL Item
    Peripheral sympatholytic (17)
    CL Item
    Central sympatholytic (18)
    CL Item
    Alpha-beta blocker (19)
    CL Item
    Beta-blocker (20)
    CL Item
    Loop-active diuretics (21)
    CL Item
    Diuretics of thiazide type (22)
    CL Item
    Potassium-sparing diuretics (23)
    CL Item
    Insulin (24)
    CL Item
    Oral hypoglycemic agents (25)
    CL Item
    Non-steroidal anti-inflammatory drugs (26)
    CL Item
    Specific Cox II inhibitors (27)
    Item Group
    ACE Inhibitors
    C0003015 (UMLS CUI-1)
    ACE Inhibitors currently taken
    Item
    3. Are ACE Inhibitors currently being taken on the day of visit 1?
    boolean
    Name of ACE Inhibitor and Total Daily Dose
    Item
    Name of ACE Inhibitor and Total Daily Dose
    text
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial